Skip to main content
Table of Contents
Print

What Do Therapists Report on Patients Using CannabisĀ forĀ Depression?Ā 

Author: Dr. Clarissa Morton, PharmD

The views of therapists on cannabis for depression vary widely, reflecting both clinical experiences and the lack of consistent research evidence. Some therapists observe that cannabis, particularly CBD, can reduce anxiety and help patients feel calmer, which may support therapy engagement. Others caution that frequent or high-THC use may interfere with focus, memory, and motivation, potentially making therapy less effective. 

In practice, many therapists highlight the importance of context. Cannabis use can be beneficial for some patients, but others may experience setbacks, depending on factors such as dose, strain, and personal sensitivity. 

Professional Perspectives on Cannabis Use 

Discussions around therapists on cannabis for depression often centre on how cannabis influences therapy dynamics and patient wellbeing. 

Clinical Perspectives 

From clinical perspectives, therapists note both potential benefits, such as reduced distress before sessions, and drawbacks like emotional blunting or avoidance of deeper issues. 

Therapist Insights 

Some therapist insights suggest cannabis may make patients more open to emotional exploration. Yet others point out that reliance on cannabis outside of therapy could slow long-term progress. 

Professional Views 

Broader professional views emphasise the need for caution. Therapists generally agree that while cannabis may offer supportive benefits, it should not replace evidence-based treatments such as psychotherapy or medication. 

In summary, reports from therapists on cannabis for depression suggest a mixed picture, with potential advantages for some patients but risks of hindering therapy for others. The key lies in individualised care and open discussion between patient and therapist. 

For those considering cannabis as part of their mental health journey, providers likeĀ LeafEaseĀ can offer confidential consultations tailored to safe and professional guidance.Ā 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical CannabisĀ and Depression.Ā 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.Ā 

Categories